产生医用放射性核素核数据的测量、理论计算与评价(续)  

Nuclear Data for Production of Therapeutic Radionuclides(Continued)

作　　者：王书暖[1] 李春晟[1] 

机构地区：[1]中国原子能科学研究院,北京102413

出　　处：《原子核物理评论》2007年第3期247-252,共6页Nuclear Physics Review

摘　　要：简要介绍产生治疗放射性核素(利用反应堆、加速器或衰变而产生的26个核素、61种不同反应途径)核数据的测量、理论计算与评价的新进展。这些核素是:已广泛用于临床的32P,89Sr,90Y,103Pd,125I,131I,137Cs,153Sm,186Re,188Re,192Ir和具有很大潜在使用可能性的64Cu,67Cu,67Ga,86Y,105Rh,111In,114mIn,124I,125I(新),149Pm,166Ho,169Yb,177Lu,211At,213Bi,225Ac。61种不同反应途径中有6种新的反应途径。为提高核医学应用的安全性和有效性,对现有核数据进行评价与适当能区的理论计算是十分必要的。The nuclear data measurements and preliminary evaluation as well as theoretical calculation for established and emerging 26 radio-nuclides produced in 61 ways by using reactor,accelerator or decay are briefly introduced.The measured data evaluation and theoretical calculation in some energy range are very important in order to keep the safety and validity in medical therapeutic applications.The 11 established radio-nuclides are 32P,89Sr,90Y,103Pd,125I,131I,137Cs,153Sm,186Re,188Re,192Ir and the 16 emerging radio-nuclides are 64Cu,67Cu,67Ga,86Y,105Rh,111In,114mIn,124I,125I（new）,149Pm,166Ho,169Yb,177Lu,211At,213Bi,225Ac.

关 键 词：医用同位素 核数据 测量 评价 计算 

分 类 号：O571[理学—粒子物理与原子核物理]